Overview
The injury and wound conditions of the enrolled patients will be documented. A follow-up at 90 days post-administration will determine the clinical outcome of tetanus prophylaxis, specifically whether tetanus occurred. The registry will also employ selective safety data collection to record adverse reactions and serious adverse events following Siltartoxatug adminstration.
Eligibility
Inclusion Criteria:
- 1.Having received or will receive Siltartoxatug for tetanus prophylaxis following injury;
- 2\. Provided signed informed consent by themselves or their legal representatives.
Exclusion Criteria:
- None